Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells

Journal of Investigative Dermatology

Volumn 122, Issue 3, 2004, Pages 805-811

  Wada, Kei ^a   Maesawa, Chihaya ^a   Akasaka, Toshihide ^a   Masuda, Tomoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Maspin; Melanocytic nevi; Melanoma; Methylation; Serine protease

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MASPIN; SERINE PROTEINASE INHIBITOR;

ALLELE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DNA MODIFICATION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MELANOMA CELL; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 1842740113     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22308.x     Document Type: Article

References (45)

1. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3618, 2001
2. Biliran H Jr, Sheng S: Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res 61:8676-8682, 2001
3. Bonner RF, Emmert-Buck M, Cole K, et al: Laser capture microdissection: Molecular analysis of tissue. Science 278:1481-1483, 1997
4. Christmann M, Pick M, Lage H, Schadendorf D, Kalna B: Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT. Int J Cancer 92:123-129, 2001
5. Clark SJ, Harrison J, Paul CL, Frommer M: High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22:2990-2997, 1994
6. Costello JF, Vertino PM: Methylation matters: A new spin on maspin. Nat Genet 31:123-124, 2002
7. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T: The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93:7149-7153, 1996
8. Domann FE, Rice JC, Hendrix MJ, Futscher BW: Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85:805-810, 2000
9. Eden A, Gaudet F, Waghmare A, Jaenisch R: Chromosomal Instability and tumors promoted by DNA hypomethylation. Science 300:455, 2003
10. Ehrlich M: DNA methylation in cancer: Too much, but also too little. Oncogene 21:5400-5413, 2002
11. Ehrlich M, Jiang G, Fiala E, et al: Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 21:6694-6702, 2002
12. Feinberg AP, Vogelstein B: Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92, 1983
13. Feng Y, Shi J, Goldstein AM, Tucker MA, Nelson MA: Analysis of mutations and identification of several polymorphisms in the putative promoter region of the P34CDC2-reated CDC2L1 gene located at 1P36 in melanoma cell lines and melanoma families. Int J Cancer 99:834-838, 2002
14. Futscher BW, Oshiro MM, Wozniak RJ, et al: Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 31:175-179, 2002
15. Gama-Sosa MA, Stagel VA, Trewyn RW, et al: The 5-methylcytostne content of DNA from human tumors. Nucleic Acids Res 11:6883-6894, 1983
16. Gaudet F, Hodgson JG, Eden A, et al: Induction of tumors in mice by genomic hypomethylation. Science 300:489-492, 2003
17. Huang Y, Peng J, Oberley LW, Domann FE: Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5′ CpG island. Free Radic Biol Med 23:314-320, 1997
18. Lete SM, Graves K, Gatalica Z: Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast. Appl Immunohistochem Mol Morphol 8:32-36, 2000
19. Maass N, Hojo T, Rosel F, Ikeda T, Jonat W, Nagasaki K: Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 34:303-307, 2001a
20. Maass N, Hojo T, Ueding M, et al: Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 7:812-817, 2001b
21. Machtens S. Serth J, Bokemeyer C, et al: Expression of the p53 and Maspin protein in primary prostate cancer: Correlation with clinical features. Int J Cancer 95:337-342, 2001
22. McGowen R, Biliran H Jr, Sager R, Sheng S: The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res 60:4771-4778, 2000
23. Mohsin SK, Zhang M, Clark GM, Allred DC: Maspin expression in invasive breast cancer: Association with other prognostic factors. J Pathol 199:432-435, 2003
24. Reis-Filho JS, Milanezi F, Paredes J, et al: Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 11:1-8, 2003
25. Reis-Filho JS, Milanezi F, Schmitt FC: Maspin is expressed in the nuclei of breast myoepithelial cells. J Pathol 197:272-273; author reply 273-274, 2002a
26. Reis Filho JS, Milanezi F, Silva P, Schmitt FC: Maspin expression in myoepithelial tumors of the breast. Pathol Res Pract 197:817-821, 2001
27. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC: Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch 441:551-558, 2002b
28. Serrano A, Tanzarella S, Lionello I, et al: Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′-deoxycytidine treatment. Int J Cancer 94:243-251, 2001
29. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93:11669-11674, 1996
30. Sheng S, Pemberton PA, Sager R: Production, purification, and characterization of recombinant maspin proteins. J Biol Chem 269:30988-30993, 1994
31. Sheng S, Truong B, Fredrickson D, Wu R, Pardee AB, Sager R: Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc Natl Acad Sci USA 95:499-504, 1998
32. Shi HY, Zhang W, Liang R, et al: Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model, Cancer Res 61:6945-6951, 2001
33. Sigalotti L, Coral S, Nardi G, et al: Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma. J Immunother 25:16-26, 2002
34. Soengas MS, Capodieci P, Polsky D, et al: Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409:207-211, 2001
35. Sood AK, Fletcher MS, Gruman LM, et al: The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8:2924-2932, 2002
36. Straume O, Smeds J, Kumar R, Hemminki K, Akslen LA: Significant impact of promoter hypermethylation and the 540 C > T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am J Pathol 161:229-237, 2002
37. Umekita Y, Ohl Y, Sagara Y, Yoshida H: Expression of maspin predicts poor prognosis in breast-cancer patients. Int J Cancer 100:452-455, 2002
38. Umekita Y, Yosida H: Expression of maspin is up-regulated during progression of mammary ductal carcinoma. Histopathotogy 42:541-545, 2003
39. Worm J, Bartkova J, Kirkin AF, et al: Aberrant p27Kip1 promoter methylation in malignant melanoma. Oncogene 19:5111-5115, 2000
40. Xia W, Lau YK, Hu MC, et al: High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19:2398-2403, 2000
41. Zhang M, Maass N, Magit D, Sager R: Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ 8:179-186, 1997
42. Zhang M, Volpert O, Shi YH, Bouck N: Maspin is an angiogenesis inhibitor. Nat Med 6:196-199, 2000
43. Zhang W, Zhang M: Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors. Int J Oncol 20:1145-1150, 2002
44. Zou Z, Anisowicz A, Hendrix MJ, et al: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526-529, 1994
45. Zou Z, Gao C, Nagaich AK, et al: p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275:6051-6054, 2000